A new pharmaceutical exception allowed operations involving cannabis or THC medicines holding the required marketing authorisation. The general cannabis prohibition and specific research and industrial authorisation routes remained. The amendment took effect two months after publication on 7 June 2019.[1]
Listed for context. No score change is recorded for Monaco here.
References
Checked. The date and the event were compared with a source that was read.